NCT00908115View on ClinicalTrials.gov

Post Market Surveillance for Infanrix™

CompletedOBSERVATIONAL
Enrollment

1,258

Participants

Timeline

Start Date

August 1, 2003

Primary Completion Date

June 23, 2008

Study Completion Date

June 23, 2008

Conditions
DiphtheriaAcellular PertussisTetanus
Interventions
BIOLOGICAL

GSK Biologicals' Infanrix™

Primary and booster vaccination according to vaccination schedule. Intramuscular injection

Trial Locations (1)

700-712

GSK Investigational Site, Daegu

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY